Nektar Therapeutics (NASDAQ:NKTR) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate of $(0.45) by 31.11 percent. This is a 55.71 percent increase over losses of $(0.70) per share from the same period last year. The company reported quarterly sales of $23.63 million which beat the analyst consensus estimate of $22.61 million by 4.49 percent. This is a 5.20 percent decrease over sales of $24.92 million the same period last year.
Innovative Eyewear, Inc. Partners With New Look Vision Group To Provide Smart Eyewear In Canada
Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ:LUCY, LUCYW)))), the developer of smart eyewear under the Lucyd®, Nautica®, Eddie Bauer® and Reebok® brands, is pleased
